Volume 38 · Number 12
DECEMBER 2008

Missing Data in Longitudinal Clinical Trials Part A: Design and Conceptual Issues

By Philip W. Lavori, PhD; C. Hendricks Brown, PhD; Naihua Duan, PhD; Robert D. Gibbons, PhD; Joel Greenhouse, PhD

There are numerous types of missing data that can occur in clinical trials. Some types of missing data cannot be prevented and are beyond the research team’s control. For example, a patient may relocate and be unavailable for an assessment. Other types occur because the research team actually designs the study to generate incomplete data. For example, it may not be cost-effective to obtain a full diagnostic assessment on each subject. Instead, an inexpensive screening tool is used to assess everyone. All screen positives, plus a random sample of screen negatives, are then given the full diagnostic. The incomplete diagnostic data on the majority of those screened negative are taken into account in assessing treatment effects.1-3 These types of data are missing by design, and there are statistical procedures to handle such planned missing data if designed appropriately. The third type occurs because of a faulty design plan by the research team. In this case, data are lost because a less than adequate protocol is followed. For example, if no screen negatives are given the full diagnostic, it will not be possible to ascertain the false negatives.

ABOUT THE AUTHORS

Philip W. Lavori, PhD, is Professor of Biostatistics, and Chair, Department of Health Research and Policy, Stanford University School of Medicine. C. Hendricks Brown, PhD, is with the Prevention Science and Methodology Group, Departments of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa. Naihua Duan, PhD, is Professor of Biostatistics in Psychiatry, Departments of Biostatistics and Psychiatry, Columbia University, New York; and Director, Division of Biostatistics, N.Y. Psychiatric Institute. Robert D. Gibbons, PhD, is Professor of Biostatistics and Psychiatry, and Director of the Center for Health Statistics, University of Illinois at Chicago. Joel Greenhouse, PhD, is with the Department of Statistics, Carnegie Mellon University, Pittsburgh.

Address correspondence to: Philip Lavori, HRP/Redwood Building, 259 Campus Drive, Stanford, CA 94305-5405; fax 650-725-6951; or e-mail lavori@stanford.edu.

Dr. Lavori, Dr. Brown, Dr. Duan, Dr. Gibbons, and Dr. Greenhouse have disclosed no relevant financial relationships.

EDUCATIONAL OBJECTIVES

  1. Describe problems associated with missing data in psychiatric research.
  2. Define how missing data can be minimized by improved experimental designs.
  3. Identify methods that should be avoided when analyzing studies with missing data.

 

Statistics — What Can You Believe? If You Care About DSM-V, Read This
Jan Fawcett, MD

Design and Analysis of Longitudinal Studies
Robert D. Gibbons, PhD

Psychiatry in the News

CE article Sample Size Determination for Studies with Repeated Continuous Outcomes
Dulal K. Bhaumik, PhD; Anindya Roy, PhD; Subhash Aryal, PhD; Kwan Hur, PhD; Naihua Duan, PhD; Sharon-Lise T. Normand, PhD; C. Hendricks Brown, PhD; Robert D. Gibbons, PhD

CE article Intent-to-treat vs. Non-intent-to-treat Analyses under Treatment Non-adherence in Mental Health Randomized Trials
Thomas R. Ten Have, PhD; Sharon-Lise T. Normand, PhD; Sue M. Marcus, PhD; C. Hendricks Brown, PhD; Philip Lavori, PhD; Naihua Duan, PhD

CE article Missing Data in Longitudinal Trials – Part B, Analytic Issues
Juned Siddique, DrPH; C. Hendricks Brown, PhD; Donald Hedeker, PhD; Naihua Duan, PhD; Robert D. Gibbons, PhD; Jeanne Miranda, PhD; Philip W. Lavori, PhD

Balancing Treatment Comparisons in Longitudinal Studies
Sue M. Marcus, PhD; Juned Siddique, DrPH; Thomas R. Ten Have, PhD; Robert D. Gibbons, PhD; Elizabeth Stuart, PhD; Sharon-Lise T. Normand, PhD

 

Sign up for the News Wire Meet the Medical Editor Meet the Editorial Board Send a Letter to the Editor